Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01899092 |
Recruitment Status :
Completed
First Posted : July 15, 2013
Last Update Posted : November 30, 2016
|
Sponsor:
Tacere Therapeutics, Inc.
Information provided by (Responsible Party):
Tacere Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | September 2016 |
Actual Study Completion Date : | November 2016 |